Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis: Victoria, British Columbia Thursday, November 14, 2024, ...
As a significant milestone in India's pharma sector, the 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26 to 28, 2024 ...
Caliway’s drug molecule CBL-514 to treat Dercum’s disease receives EMA orphan drug designation: New Taipei City Thursday, November 14, 2024, 16:00 Hrs [IST] Caliway Biopharmac ...
AstraZeneca India and Indian Academy of Paediatrics Unite to raise awareness on respiratory syncytial virus in India: Our Bureau, Bengaluru Thursday, November 14, 2024, 16:45 Hrs ...
IDF research reveals diabetes impacts the mental well-being of over 4 in 5 Indians living with the condition: Our Bureau, Bengaluru Thursday, November 14, 2024, 15:45 Hrs [IST] In ...
Biocon Academy achieves 100% placement for its 6th batch and concludes 5th edition of MCADDI residential programme for industry: Our Bureau, Bengaluru Thursday, November 14, 2024, ...
Survey shows unsustainable regulatory workloads leave no choice about AI adoption: Boston, Massachusetts Thursday, November 14, 2024, 17:00 Hrs [IST] ArisGlobal, an innovative tec ...
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers: London, UK Thursday, November 14, 2024, 15:00 Hrs [IST] GSK plc announced t ...
Researchers uncover new role of mutant proteins in some of the deadliest cancers: Maryland Thursday, November 14, 2024, 13:00 Hrs [IST] Researchers at the National Institutes of H ...
Mississauga, Ontario Thursday, November 14, 2024, 09:00 Hrs [IST] ...
Pharma Programme, that the Pradhan Mantri Scholarship for Pharmacy Postgraduate Studies (PMSPPS) will be awarded to eligible ...
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...